Immunotherapy Toxicity: Identification and Management
Last Updated: Tuesday, March 7, 2023
Using data from recent clinical trials, this review focuses on known immune-related adverse events, particularly those seen in patients with breast cancer, and will summarize their prevalence, severity, and outcomes. The authors discuss optimal strategies for early recognition and management, as well as approaches toward cautious retreatment following the resolution of immune-related adverse events.
Advertisement
News & Literature Highlights